ML20248H326

LTR-20-0332 David Adams, Chief Operating Officer, Midlantic Urology, Letter Support for Revising the Regulations for Training and Experience Requirements to Allow non-nuclear Physicians to Prescribe and Administer Unsealed Radiopharmaceutic

ML20248H326
Person / Time
Issue date:	07/22/2020
From:	Darrell Adams MidLantic Urology
To:	Kristine Svinicki NRC/Chairman
Shared Package
ML20248H327	List: ML20248H326
References
LTR-20-0332
Download: ML20248H326 (2)